๐๏ธ Verified NIH Record โข Updated 2026-07-17
HEALEY ALS Platform Trial - Regimen I NUZ-001 (NCT07410806)
๐ต Active, Not Recruiting Phase2 / Phase3 ๐ Investigational Drug / Biologic Sponsor: Merit E. Cudkowicz, MD
๐ฉบ Plain-English Summary (8th-Grade Level)
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS. Regimen I will evaluate the safety and efficacy of a single study drug, NUZ-001, in participants with ALS.
Who can join: Review the eligibility criteria below.
Location: Healey Center for ALS at Massachusetts General Hospital โ Boston, Massachusetts
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Healey Center for ALS at Massachusetts General Hospital โ Boston, Massachusetts
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Amyotrophic Lateral Sclerosis (ALS)
- A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) โ La Jolla, California
- Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY) โ Phoenix, Arizona
- Resiliency Intervention for Patients With ALS and Their Care-Partners โ Boston, Massachusetts
- Safety Study of XT-150 in Participants With ALS โ Phoenix, Arizona
- A Phase โ /โ กa Study of SNUG01 in Adult Subjects With ALS โ Boston, Massachusetts
Explore by condition: All Amyotrophic Lateral Sclerosis (ALS) clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.